Don Haynie earned a doctorate in biophysics from Johns Hopkins University. His thesis research was on thermodynamic properties of proteins. He was then awarded a fellowship by the National Science Foundation for post-doctoral study on biological macromolecules at University of Oxford. He has lived in Taiwan and Germany in addition to the USA and UK. He has been a lecturer in biochemistry, Assistant Research Professor of Physics, Associate Professor of Biomedical Engineering and Physics, Research Professor of Biochemistry and Biophysics, and Director of the Bionanosystems Engineering Laboratory. He has been invited to give scientific presentations in the USA, UK, China, India, Mexico, Portugal, Spain and Greece. His research has been supported by the National Science Foundation, National Institutes of Health, Air Force Office of Scientific Research, National Aeronautics and Space Administration, Royal Society, Medical Research Council and other agencies. Results of his research are published in ACS Nano, Applied Physics Letters, Bioelectromagnetics, Biomacromolecules, Biopolymers, Biotechnology Progress, Cell Proliferation, International Journal of Nanomedicine, Journal of Biomaterials Science Polymer Edition, Journal of Biomedical Materials Research, Journal of Molecular Biology, Journal of Nanoscience and Nanotechnology, Langmuir, Macromolecules, Nano Letters, Nanomedicine NBM, Nanotechnology, Nature Structural Biology, Pharmaceutical Technology, Physics in Medicine and Biology, Proteins, Protein Science and other journals. He is a fellow and a member of the board of directors of the American Academy of Nanomedicine. He is Associate Editor of Nanomedicine: Nanotechnology, Biology, and Medicine and a member of the editorial advisory board of Recent Patents in Biotechnology and Recent Patents in Nanotechnology. He has multiple issued and pending patents. He founded Artificial Cell Technologies, Inc. to commercialize designed polypeptide multilayer nanofilms. The company is located in Science Park at Yale, New Haven, Connecticut. Former members of his research group have held positions at King’s College London, Pacific Nanotechnology, EPMedSystems, Harvard Medical School, AstraZeneca, University of West Virginia School of Medicine, Wyeth, University of Chicago School of Medicine, Purdue University, KineMed, Inc. and other institutions.
